William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

AVXL Stock: 6 Things for Investors to Know About Anavex Life Sciences

Anavex Life Sciences (AVXL) stock is soaring higher Thursday on heavy trading despite a lack of news concerning the company.

APPS Stock: 7 Things to Know About Digital Turbine as Shares Zip Higher

Digital Turbine (NASDAQ:APPS) is seeing shares of APPS stock soar higher on Thursday and InvestorPlace has all the details for investors.

VGAC Stock: 15 Things to Know About 23andMe and the Virgin Group SPAC Merger

23andMe has revealed plans to go public via a SPAC merger with VG Acquisition (VGAC) and shares of VGAC stock are soaring on Thursday.

AREC Stock: 7 Things for Investors to Know About Rare Earth Play American Resources

American Resources (AREC) stock is soaring higher on Wednesday after announcing a deal to boost its rare earth capabilities.

Fintech News: FTOC Stock Surges on Payoneer SPAC Merger Approval

Payoneer is going public thanks to a merger with SPAC FTAC Olympus Acquisition (FTOC) and FTOC stock is on the move Wednesday.

GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal

GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company.

MVIS Stock: 11 Things for Potential Investors to Know About MicroVision

MicroVision (MVIS) stock is on the rise Wednesday despite a lack of news concerning the creator of LiDAR sensors for self-driving cars.

Cannabis Stocks: Why TLRY, ACB, CGC, APHA and SNDL Stocks Are Surging Wednesday

Cannabis stocks are heading higher Wednesday as investors hope for national legalization of the drug following comments from Chuck Schumer.

SAVA Stock: 12 Things for Investors to Know About Cassava Sciences as Shares Soar

Cassava Sciences (SAVA) stock is on the rise Wednesday after revealing interim results from a recent Alzheimer’s disease clinical trial.

Amazon HQ2: 9 Design Features to Make Corporate Employees Jealous (Hint: There’s a Helix)

Amazon (AMZN) has revealed what its HQ2 building will look like and it's nothing to sneeze at with its incredibly unique design.